OAR 855-115-0340: Services: Prescribing - Formulary
Edition: Current OARD snapshotEffective: 2026-01-23Last verified: 2026-09-07
A Pharmacist may prescribe, according to OAR 855-115-0330 and OAR 855-115-0335, an FDA-approved drug and device listed in the Formulary, pursuant to a diagnosis by a health care practitioner who has prescriptive authority and who is qualified to make the diagnosis. Formulary devices and supplies: (1) Diabetic blood sugar testing supplies; (2) Injection supplies; (3) Nebulizers and associated supplies; (4) Inhalation spacers; (5) Peak flow meters; (6) International Normalized Ratio (INR) testing supplies; (7) Enteral nutrition supplies; (8) Ostomy products and supplies; and (9) Non-invasive blood pressure monitors; and (10) Continuous glucose monitors and associated supplies; and (11) Epinephrine.
Official history and status
Statutory/Other Authority: ORS 689.205
Statutes/Other Implemented: ORS 689.645 & ORS 689.649
History: BP 2-2026, amend filed 01/23/2026, effective 01/23/2026 BP 11-2025, minor correction filed 09/05/2025, effective 09/05/2025 BP 6-2025, amend filed 08/08/2025, effective 08/08/2025 BP 54-2024, amend filed 06/18/2024, effective 06/20/2024 BP 16-2023, adopt filed 08/16/2023, effective 03/01/2024
This rule cites
- OAR 855-115-0330 — resolved
- OAR 855-115-0335 — resolved
Cited by
Official source: https://secure.sos.state.or.us/oard/